Aims-To compare the effectiveness of three computerised systems that are currently used for assisting warfarin control in outpatients with the customary dosing method used by experienced medical staff. Methods-A pilot randomised study of three systems with a follow up independently randomised study of two of these was made on 186 patients receiving long term treatment or who had recently started warfarin treatment and had been discharged from hospital. Results-All three computerised systems seemed to give satisfactory control compared with the traditional dosing method. For patients receiving more intensive treatment with an assigned target range of 3.0-4.5 computerised dosage programs achieved significantly better control; the medical staff undertreated such patients almost 50% of the time. Conclusion-Computer based programs can assist outpatient anticoagulant control with warfarin during both early and long term treatment. For most patients the control achieved is as good as that obtained by the customary method of dosing, by experienced clinic doctors, although the latter tend to be too conservative when dosing patients within the intense target range of 3 0 to 4 5 International Normalised Ratio (INR). The computers were significantly more successful in this higher range. (7 Clin Pathol 1993;46:299-303) 
Warfarin and other related oral anticoagulant drugs are widely prescribed in hospital practice for a variety of clinical disorders. Monitoring the patient's prothrombin time response to these drugs on the basis of the International Normalised Ratio (INR), and adjustment of the dose to achieve a target INR range, is costly in terms of medical and administrative time.
The degree of anticoagulant control achieved varies considerably between centres. Previous surveys have found that patients are adequately anticoagulated from 50-85% of the time. I 2 There has been increasing interest in the value of computer-based dosage programs to assist in the control of outpatients receiving warfarin treatment. The observations from earlier studies suggest that such programs may assist and improve control of long term warfarin treatment.3-5 They also seem to reduce demands on medical and secretarial time.
At present there is little experience with such programs during the early stage of warfarin treatment which follows discharge from hospital. There are also no comparative data on the efficacy of the various systems or controlled studies of their reliability in dosing compared with the traditional method.
The aim of the present controlled study was to determine the feasibility of computerised dosing during this critical early phase. We also undertook to compare its effectiveness with the customary dosing method for patients during long term warfarin and those recently started on treatment. We confined this study to the assessment of the degree of control of dosage achieved by the systems. We have not attempted to evaluate their additional functions which include audit and clinic administration.
Methods
The customary method of dosing by experienced medical staff in an anticoagulant clinic was studied alongside the following three computerised dosage programs: 1 the Hillingdon system AC version 3 1 -a model derived from that used at both Hillingdon3 and Chesterfield4 to control warfarin treatment in outpatients. 2 Hillingdon  dosing  system  system  system  Total   Venous thrombo-embolism  24  24  19  7  74  Arterial disease  20  18  14  4  56  Lone atrial fibrillation  6  5  12  0  23  Rheumatic heart disease  7  3  5  0  15  Cerebrovascular disease  3  3  3  1  10  Others  4  4  0  0  8  Total  64  57  53  12  186 were again entered into the study. and more cases of atrial fibrilation, with or without rheumatic heart disease, in the long term group. No significant differences were found between the results obtained from the two periods of randomisation, and therefore the data from the two studies were combined into a single analysis. The number of readings available with the Hillingdon system was too small to allow significant differences to be established between it and the other three methods.
The results obtained with the four methods are compared in table 2. Dosing by the clinic doctors maintained patients' INR values within the target range on 504% of visits whereas the respective figures for the Charles, Coventry, and Hillingdon programs were 56 5%, 53 1%, and 55 8% of visits. Overall, there was no significant difference in the control achieved by the four methods (X2 3 = 2-05; p = 0 57). The computer generated time interval to the next visit was reduced on 16 occasions: by 1-8% in the case of the Charles system and 7-8% for the Coventry program. Advice generated by the Hillingdon system required amendment on 11-7% of visits which included two dosage adjustments. Dosing by all four methods was more likely to lead to undertreatment than overtreatment (INR values below rather than above the INR target range). The mean time interval between visits was similar for customary dosing, the Charles, and the Coventry systems. For the Hillingdon program, more frequent visits resulted (table 2) . When the results were analysed with respect to the two target ranges differences became apparent (table 5) . For patients assigned a 3 0-4A5 target band, computerised dosing was more effective in maintaining the INR within range (on 56-0% and 58-6% of visits for the Charles and Coventry systems, respectively) than traditional dosing (36-8% of visits). This achieved significance (22 (3) = 8-05; p = 0044). For the last group patients were underanticoagulated on 48-4% of visits. The improved control obtained with the Hillingdon system was not as pronounced (45 5% of visits within range). Patients assigned this higher range and dosed by the Coventry system were almost twice as likely to be overanticoagulated than by any of the other methods.
For the 2-0-3-0 range patients dosed using the traditional method seemed to be slightly better-INR values within range on 59 7% of visits, followed by the Hillingdon system 59 4%, the Charles at 56-8%, and Coventry at 51.5%, but the differences were not significant (X2 (3) = 1-79; p = 0.62). For the less intense range all methods, including the Coventry, were more likely to undertreat than overtreat patients.
One patient dosed by the Coventry system died while in the study. His 
(BCR) range of 2{04-0. 4 Taking an INR range of 2 0-4 5 to define satisfactory anticoagulation, our traditionally dosed patients were adequately treated on 74% of visits. This is similar to the figure of 75-7% for patients attending our anticoagulant clinics over the past six years and compares favourably with the results of earlier studies.
For those patients dosed by any of the three computer systems the control achieved was very close to that obtained with experienced medical staff dosing. Use of the Charles system at St Thomas's also failed to demonstrate any major improvement in anticoagulant control.8 Our finding that on 56-5% of visits patients dosed by Charles method had INR values within range, is remarkably close to the figure of 55% achieved there.
Earlier reports on the use of the Hillingdon program indicated much better control than we have observed.349 Our inclusion of early warfarin control and the use of narrower therapeutic INR intervals to define satisfactory control would presumably largely account for the difference. After the first period of randomisation use of the Hillingdon program was discontinued because of the increased need to amend dosage and interval suggestions (11-7% of visits) compared with the other systems. Operating the program also proved relatively cumbersome and it resulted in patients attending more frequently than did use of the other methods. Consequently the total number of dosings obtained with the Hillingdon program is comparatively small, making it difficult to draw any firm conclusions about its efficacy, particularly when analysing subgroups of patients.
Adoption of the Coventry program in South Warwickshire has resulted in a progressive increase in the proportion of patients with INRs within the therapeutic range, from 45-3% to 62-9%, over a six month period.5 The data presented in that study, however, were confined to those patients assigned a target range of 3 0-4 5. For this subgroup we also observed significantly better control with the Coventry system (58-6% of visits in range compared with 36-8% for traditional dosing). It is of concern, however, that for those more intensely treated patients use of the Coventry program resulted in their INR values being greater than 4 5 on more than a quarter of visits. The Charles system also performed favourably within this group (INR in range on 56-0% of visits). Medical staff seem to be overly cautious when dosing patients within the higher target range, such that these patients remained undertreated almost 50% of the time.
The alteration in diet and lifestyle associated with discharge from hospital make warfarin requirements unstable at that time.
Copplestone and Roath' found that during the initial three months of treatment patients were adequately anticoagulated 69% of the time compared with 88% of the time for patients running long term anticoagulation (using a BCR range of 2.0-4 0). In contrast, we found that customary dosing and dosing by the Conventry system achieved slightly better control in patients who had recently started treatment than for those receiving long term treatment, although the difference was not significant.
The finding that advice generated by computer systems needed alteration on only 3 1 % of visits was unexpected. Use of the Charles system at St Thomas's had found that 20% of decisions required amendment (unpublished data) compared with just 1 8% in our study.
We have shown that computerised dosage programs can reliably assist anticoagulant control during both early and long term warfarin treatment; less than 4% of generated advice needed revision. However, overall control achieved is comparable with, but no better than, that obtained with the customary method of dosing by experienced medical staff.
Varying levels of computer involvement in outpatient warfarin management can be envisaged:
1 to conduct the anticoagulant clinic on traditional lines-all dosing performed manually with record keeping by hand; 2 to use the computer to monitor the audit and administrative aspects of the clinic only. All dosing to be carried out by medical staff; 3 to conduct the medical staff interview and dosing of patients with a lap-top computer system available in the clinic to provide dose suggestions to assist the clinician; 4 to allow the computer to prescribe for patients with stable dose requirements, leaving medical staff to concentrate on improving the control of the minority of patients with poor compliance, etc; 5 to fully computerise the clinic, so that at their attendance patients simply give a blood sample. The warfarin dose is computer generated and sent to the patient by post. No medical contact is required with this option. Neither options 1 or 5 seem to be the best because of practical and safety considerations, respectively. Of the remaining three possibilities, each centre running an anticoagulant clinic should adopt the one which best fits with local requirements. For those hospitals with sufficient clinic accommodation, time, and experienced staff option 2 seems to be reasonable. When newly appointed staff are participating in the clinic then option 3 would allow the inexperienced doctor to gain confidence with dosing by having a second opinion in the clinic room alongside him or her. In centres where clinic space is restricted or absent and dosing is performed by junior house staff rushing off to deal with more pressing medical problems then option 4 may be preferred.
To conclude, where experienced medical staff participate in well run clinics, dosing in the traditional manner, computer dosage systems should not be expected to improve anticoagulant control within the lower INR range of 2 to 3. They might, however, still be considered for their other advantages in documentation and administration.
